DLBD Technologies is a software company for regulated industries. Five sellable products and a fully integrated Suite for co-manufacturers and vertically integrated brands, all on one platform that incumbents cannot cheaply match.
Incumbents in this market sell what looks like one platform but is really five acquired products stapled together. Their integration cost — for them and for their customers — is the entire product experience. DLBD ships every application on one platform: the same identity, the same audit trail, the same signing controls, the same approval logic, the same tenant isolation. The second product a customer adopts costs almost nothing to trust; theirs is a second implementation project.
The controls a regulator cares about — attributed audit trail, meaningful electronic signatures, per-organization isolation that never leaks — are one implementation shared by every application. Match that from a portfolio of acquired products and you rebuild the whole stack.
Every DLBD customer gets Covalent, our migration engine. Migration stops being a professional-services line item and becomes a diagnostic engagement the customer wants — with the class of migration errors that make headlines in this industry designed out of the process itself. This is the piece that turns bake-off wins into live customers in months instead of a year.
The received lot, the sample tested from it, the batch it went into, the shipment it left on, and the recall drill that reaches every downstream customer are one connected record. Competitors sell that as several separate integration projects.
The 2027 administrative-systems wave lands as paid add-ons to the operational products — finance, sales, HR — extending the customer we already have instead of asking them to trust a second product line. Same customer, higher account value, no second implementation.
The customers where DLBD wins today, and the ones the roadmap opens.
| Segment | Shape | Displaces | How it is sold |
|---|---|---|---|
| Contract testing labs | 5–50 analysts | QBench, LabLynx, spreadsheets | Annual licence sized to the lab; unlimited users from Professional |
| GMP CDMOs and brands | Supplements, cosmetics, food, cannabis, medtech I–II | Paper batch records, Excel; Apprentice / Tulip later | QMS + batch-record bundle; unlimited users from Professional |
| Mid-market QMS | 20–200 employees | Qualio, ZenQMS, down-market MasterControl | Annual licence; unlimited users from Professional |
| GxP labs needing an ELN | 10–100 scientists | Paper, SciNote, eLabNext, LabArchives | Per-scientist licence, or site licence with LIMS/QMS |
| Regulated distributors / 3PLs | GDP scope | Fishbowl, clipboards | Attach to Manufacturing or LIMS; standalone for GDP distributors |
The products are shipped and in customer hands. The enterprise buyer bar — identity, security posture, validation evidence — is largely cleared. Covalent, our migration engine, ships to every customer and shortens the gap between a bake-off win and a live customer. The 2027 administrative-systems wave lands as paid add-ons that extend the customer we already have. Nothing on the plan requires DLBD to become a different kind of company to deliver.
Their integration cost is structural. They cannot compress it without rebuilding on a platform they do not have — which their existing customer base will not tolerate.
A customer scaling from a single-product tool into full manufacturing runs out of runway. The next product they need is not made by their current vendor.
Regulators are formalizing that AI cannot sit on the signature path. Our posture — draft assistance, human-signed, fully audited — is the one the rules are landing on anyway.
Covalent — our migration engine — ships to every customer. The gap between a bake-off win and a live customer collapses because we removed the reason it exists.
We share detailed materials with qualified investors under NDA. Reach out and we will set up a call.